You have already added 0 works in your ORCID record related to the merged Research product.
You have already added 0 works in your ORCID record related to the merged Research product.
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
these results were also confirmed after random matching by age and sex (1:1:1). No significant differences were found in demographic, clinical, treatment, and laboratory features. Among MS patients positive to SARS-CoV-2 IgG/IgM (n = 9), only two patients retrospectively reported mild and short-lasting COVID-19 symptoms. Conclusions. MS patients have similar risk of SARS-CoV-2 infection to the general population, and can be asymptomatic from COVID-19, also if using treatments with systemic immunosuppression.
Background. We compared the prevalence of SARS-CoV-2 IgG/IgM in multiple sclerosis (MS), low-risk, and high-risk populations and explored possible clinical correlates. Methods. In this cross-sectional study, we recruited MS patients, low-risk (university staff from non-clinical departments), and high-risk individuals (healthcare staff from COVID-19 wards) from 11 May to 15 June 2020. We used lateral flow immunoassay to detect SARS-CoV-2 IgG and IgM. We used t-test, Fisher&rsquo
females 54.5%). The prevalence of SARS-CoV-2 IgG/IgM in MS patients (n = 9, 2.9%) was significantly lower than in the high-risk population (n = 25, 10.6%) (p <
s test, as appropriate, to evaluate between-group differences. Results. We recruited 310 MS patients (42.3 ±
0.001), and similar to the low-risk population (n = 11, 1.3%) (p = 0.057)
females 47.8%), and 235 high-risk individuals (39.4 ±
females 67.1%), 862 low-risk individuals (42.9 ±
s exact test, chi square test, or McNemar&rsquo
13.3 years
10.9 years
12.4 years
- Sapienza University of Rome Italy
- Imperial College London United Kingdom
- Federico II University Hospital Italy
- University Federico II of Naples Italy
Microsoft Academic Graph classification: medicine.medical_specialty Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Population Asymptomatic McNemar's test Internal medicine Chi-square test medicine Seroprevalence education education.field_of_study biology business.industry Multiple sclerosis medicine.disease Exact test biology.protein Antibody medicine.symptom business
Library of Congress Subject Headings: lcsh:Medicine lcsh:R
COVID-19; antibody; infection; multiple sclerosis; seroprevalence, multiple sclerosis, Article, antibody, seroprevalence, R, COVID-19, General Medicine, infection, Neurology, multiple sclerosi, Medicine, Neurology (clinical)
COVID-19; antibody; infection; multiple sclerosis; seroprevalence, multiple sclerosis, Article, antibody, seroprevalence, R, COVID-19, General Medicine, infection, Neurology, multiple sclerosi, Medicine, Neurology (clinical)
Microsoft Academic Graph classification: medicine.medical_specialty Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Population Asymptomatic McNemar's test Internal medicine Chi-square test medicine Seroprevalence education education.field_of_study biology business.industry Multiple sclerosis medicine.disease Exact test biology.protein Antibody medicine.symptom business
Library of Congress Subject Headings: lcsh:Medicine lcsh:R
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).19 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10% citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).19 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10% Powered byBIP!